Quality Control Testing. SUPPLIER shall perform quality control testing in accordance with the Specifications for release of each Lot of Product to SPONSOR. SUPPLIER shall provide all such testing data to SPONSOR in the form of a COA. Each COA shall be in accordance with the format approved by SPONSOR, certifying that the Product has met all Specifications. Any third party or contract laboratory used for the testing of the Product must be approved in writing by SPONSOR prior to its use for that purpose, such approval not to be unreasonably withheld or delayed.
Quality Control Testing. All production batches of Manual Test Kits shall be manufactured in accordance with the current Good Manufacturing Practice regulations and the Quality System Regulations promulgated by the FDA, including 21 C.F.R. Part 820 and tested in accordance with appropriate quality control testing procedures prior to shipment to HDL, and Manual Test Kits failing such testing shall not be shipped to HDL.
Quality Control Testing. All quality control testing of Product to be performed by Paragon shall be specified and agreed to in advance. Paragon, or a designated Qualified Subcontractor, shall perform such testing on Batches as set forth in the applicable Master Manufacturing Record, or as otherwise mutually agreed in writing by Paragon and Client.
Quality Control Testing. Any Party responsible for the manufacture of Tositumomab or Iodine I 131 Tositumomab shall maintain a quality control and testing program consistent with GMP, as required by the FDA and/or any other governmental entity whether in the United States or part of another applicable foreign jurisdiction, with respect to the manufacture by or on behalf of either Party hereunder; provided that regarding such requirements in the Territory, Corixa shall be obligated to comply only with requirements of the EU itself and not of individual countries or territories within the Territory to the extent such requirements may differ from those of the EU. Corixa shall be entitled to audit the quality control program for the manufacture of Tositumomab and Iodine I 131 Tositumomab that is manufactured by Amersham. Each Party shall bear its own expenses for such audits.
Quality Control Testing. Penwest shall perform routine quality control tests with respect to all Formulated TIMERx as required by the FDA, or otherwise as Penwest deems necessary in accordance with its applicable policies, and Penwest will also bear the expenses and fees for filing the Drug Master File for TIMERx with the FDA. No other or special tests by Penwest with respect to the raw materials or Formulated TIMERx will be required, unless and to the extent that Endo establishes that the same are required in order to obtain or maintain a governmental license to market the Product in the Territory. Penwest shall promptly, upon completion of each lot or batch of Formulated TIMERx, deliver to Endo a copy of the record of such test performed on said lot or batch. Endo will perform quality control tests on Formulated TIMERx immediately on receipt at its, or its designee's, facility and advise Penwest within thirty (30) days of any deviations from Specifications.
Quality Control Testing. Supplier and/or Manufacturer shall perform quality control testing in accordance with the Specifications and Supplier’s DMF for release of each Lot of Product to Kala. Quality control testing shall include all testing associated with the production of the Product, including, but not limited to, incoming component and raw material testing, in process testing, and final release testing. Supplier shall provide all such testing data to Kala in the form of a COA. Each COA shall be in accordance with the format approved by Kala, as exemplified in Exhibit C, certifying that the Product has met all Specifications. Supplier shall notify Kala in writing of any third party or contract laboratory used for the testing of the Product. In the event that Kala requires Supplier to perform any additional testing, such testing shall be performed at Kala’s cost and expense.
Quality Control Testing. The Global Fund shall contract an independent third-party to conduct random quality control testing of products being procured pursuant to the criteria in clause (j)i or ii above to ensure the quality of such products. The Principal Recipient shall permit (and shall ensure that Sub-recipients permit) such third party (and/or its agents) to access its storage sites and to remove samples of products procured pursuant to the criteria in clause (j)i or ii above for such analysis. In addition, the Principal Recipient shall ensure that its contracts with suppliers for Health Products include:
Quality Control Testing. The HMA producer shall provide a quality control (QC) technician who is certified by the Society of Asphalt Technologists of New Jersey as an Asphalt Technologist, Level 2. The QC technician may substitute equivalent technician certification by the Mid-Atlantic Region Technician Certification Program (MARTCP). Ensure that the QC technician is present during periods of mix production for the sole purpose of quality control testing and to assist the ME. The ME will not perform the quality control testing or other routine test functions in the absence of, or instead of, the QC technician. The QC technician shall perform sampling and testing according to the approved quality control plan, to keep the mix within the limits specified for the mix being produced. The QC technician may use acceptance test results or perform additional testing as necessary to control the mix. To determine the composition, perform ignition oven testing according to AASHTO T 308 and aggregate gradation according to AASHTO T 30. For each acceptance test, perform maximum specific gravity testing according to AASHTO T 209 on a test portion of the sample taken by the ME. Sample and test coarse aggregate, fine aggregate, mineral filler, and RAP according to the approved quality control plan for the plant. When using RAP, ensure that the supplier has in operation an ongoing daily quality control program to evaluate the RAP. As a minimum, this program shall consist of the following:
Quality Control Testing a) Contractor insisting on transporting quality control (QC) samples from the construction site to the lab.
Quality Control Testing. NASTECH shall perform, at its quality control laboratories, such quality control tests as are indicated in the SPECIFICATIONS, in accordance with the test methods and procedures. NASTECH shall make the results of its quality control tests available to MERCK on or before the date of DELIVERY of the corresponding batches of PRODUCT. No Production batch of PRODUCT shall be released for DELIVERY unless NASTECH's tests show the PRODUCT to meet the standards set forth in the SPECIFICATIONS. Should any production batch fail to meet the standards set forth in the SPECIFICATIONS, MERCK may, at its option, investigate the cause of such failure or require NASTECH to do so and to provide MERCK with a written report summarizing the results of NASTECH's investigations. MERCK shall perform such confirmatory testing of PRODUCT released for DELIVERY to MERCK as MERCK may deem appropriate, which may include, but is not limited to, the recommended procedures set forth in the SPECIFICATIONS. MERCK shall advise NASTECH of any failure of such PRODUCT to meet the standards set forth in the SPECIFICATIONS without undue delay.
